Teachers Advisors LLC Sells 169,325 Shares of Danaher Corporation (DHR)
Teachers Advisors LLC cut its holdings in Danaher Corporation (NYSE:DHR) by 16.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 869,857 shares of the conglomerate’s stock after selling 169,325 shares during the quarter. Teachers Advisors LLC owned about 0.13% of Danaher Corporation worth $73,407,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Waldron LP acquired a new position in shares of Danaher Corporation during the first quarter worth about $320,000. Empire Life Investments Inc. increased its stake in shares of Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock worth $6,662,000 after acquiring an additional 1,764 shares during the period. Ropes Wealth Advisors LLC increased its stake in shares of Danaher Corporation by 21.8% during the first quarter. Ropes Wealth Advisors LLC now owns 6,066 shares of the conglomerate’s stock worth $519,000 after acquiring an additional 1,085 shares during the period. Lee Danner & Bass Inc. increased its stake in shares of Danaher Corporation by 0.4% during the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after acquiring an additional 10 shares during the period. Finally, DE Burlo Group Inc. increased its stake in shares of Danaher Corporation by 17.8% during the first quarter. DE Burlo Group Inc. now owns 131,450 shares of the conglomerate’s stock worth $11,242,000 after acquiring an additional 19,900 shares during the period. Institutional investors own 75.66% of the company’s stock.
In related news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $83.03, for a total transaction of $878,291.34. Following the completion of the sale, the director now directly owns 42,151 shares in the company, valued at $3,499,797.53. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total transaction of $618,790.26. Following the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 71,496 shares of company stock valued at $5,916,223. 12.20% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.watchlistnews.com/teachers-advisors-llc-sells-169325-shares-of-danaher-corporation-dhr/1633803.html.
Danaher Corporation (NYSE DHR) opened at 86.84 on Monday. The company’s 50 day moving average is $85.95 and its 200 day moving average is $84.19. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The stock has a market cap of $60.33 billion, a P/E ratio of 27.72 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company posted $0.90 earnings per share. Equities analysts predict that Danaher Corporation will post $3.96 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.64%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 17.83%.
A number of brokerages have recently issued reports on DHR. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price target (up from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research note on Thursday, October 5th. J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a research note on Friday, September 8th. Cowen and Company reiterated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research note on Wednesday, October 4th. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a research note on Tuesday, September 26th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. Danaher Corporation currently has a consensus rating of “Buy” and an average price target of $92.62.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.